Method of conferring a protective immune response to norovirus
US11040097B2 · kind B2 · utility
2Cited by
33References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 8, 2020 |
| Grant date | Jun 22, 2021 |
| Priority date | — |
| Expiry date | May 8, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/16034
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to vaccine compositions comprising Norovirus antigens and adjuvants, in particular, mixtures of monovalent VLPs and mixtures of multivalent VLPs, and to methods of conferring protective immunity to Norovirus infections in a human subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.